Gaush Meditech Ltd Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Zhao Xinli, was filed 02 Sept 2025.
Gaush Meditech Ltd: what insiders have been doing
This page follows insider dealings at Gaush Meditech Ltd as filed with HKEX. In the past year (20 October 2025 to 20 October 2026), 1 filing came from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Over the last twelve months, not one insider purchase of Gaush Meditech Ltd stock was filed.
Compared with its exchange (1,318 companies, median 4 filings), a count of 1 filing is below the norm. Our records for Gaush Meditech Ltd go back to 2022, with 8 purchases and no sales on the open market in total.
For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -42.9%Entry HK$8.22 · Close at T+365 HK$4.69
- -17.5%Entry HK$10.80 · Close at T+365 HK$8.91
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 31,721,948 sharesShareXHKGHKEX:DA20260604E00559
- 5,900 shares@ HK$7.371.9% of flowShareXHKGHKEX:DA20250902E00015Canonical exit: 27 Nov 2025 (T+90)
- 5,100 shares@ HK$5.201.3% of flowShareXHKGHKEX:DA20250410E00142Canonical exit: 8 Jul 2025 (T+90)
- 5,900 shares@ HK$5.151.4% of flowShareXHKGHKEX:DA20250410E00139Canonical exit: 7 Jul 2025 (T+90)
- 59,900 shares@ HK$10.0030.2% of flowShareXHKGHKEX:DA20241224E00009Canonical exit: 20 Mar 2025 (T+90)
- 10,000 shares@ HK$9.955.0% of flowShareXHKGHKEX:DA20241224E00008Canonical exit: 19 Mar 2025 (T+90)
- 122,000 shares@ HK$9.893560.1% of flowShareXHKGHKEX:DA20241127E00244Canonical exit: 23 Feb 2025 (T+90)
- 447,100 shares@ HK$10.5439.6% of flowShareXHKGHKEX:DA20241107E00404Canonical exit: 4 Feb 2025 (T+90)
- 761,400 shares@ HK$9.6760.4% of flowShareXHKGHKEX:DA20240923E00102Canonical exit: 18 Dec 2024 (T+90)
- 955,879 sharesShareXHKGHKEX:DA20221219E00280
- 7,112,360 sharesShareXHKGHKEX:DA20221219E00281
- 3,436,116 sharesShareXHKGHKEX:DA20221219E00278
- 63,263,528 sharesShareXHKGHKEX:DA20221219E00279
13 of 13 declarations
About Gaush Meditech Ltd
Gaush Meditech Ltd is a company specializing in the medical technology sector, providing innovative solutions for diagnosis and treatment. It focuses on developing products that enhance healthcare and treatment efficiency.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations